Model
Edge
Lineage Cell Therapeutics
0001310683
Filing type
4
Filing date
Mar 5, 2026
Updated
Mar 6, 2026 ยท 5:51 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership